NCT05032521View on ClinicalTrials.gov

Treatment of Hyperlactatemia in Acute Circulatory Failure Based on Analysis of CO2: a Prospective Randomized Superiority Study (The LACTEL Study)

PHASE4CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

November 2, 2021

Primary Completion Date

November 30, 2023

Study Completion Date

November 30, 2023

Conditions
HyperlactatemiaActue Circulatory Failure
Interventions
BIOLOGICAL

collection of biological data

collection of biological data

OTHER

collection of demographic, ventilatory, cardiac echocardiography, arterial and venous gas data

These data are usually measured continuously (monitoring of the resuscitation patient) and recorded on recorded on the resuscitation software.

PROCEDURE

Standard treatment

usual management based on the use of drugs according to international recommendations

PROCEDURE

stratified treatment according to algorithm

management based on arteriovenous CO2 gradient Stratification of drug use

Trial Locations (1)

21000

Chu Dijon Bourgogne, Dijon

All Listed Sponsors
lead

Centre Hospitalier Universitaire Dijon

OTHER

NCT05032521 - Treatment of Hyperlactatemia in Acute Circulatory Failure Based on Analysis of CO2: a Prospective Randomized Superiority Study (The LACTEL Study) | Biotech Hunter | Biotech Hunter